LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 59.85 | 27.76 | 678 | 6062 | 0.1118 | 0.5087 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 59.85 | 27.76 | 2185 | 6062 | 0.3604 | 0.7539 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 61.56 | 27.76 | 1672 | 6217 | 0.2689 | 0.6903 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 61.56 | 27.76 | 1705 | 6217 | 0.2742 | 0.6946 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 61.56 | 27.76 | 679 | 6217 | 0.1092 | 0.5061 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 61.56 | 27.76 | 2197 | 6217 | 0.3534 | 0.7505 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.26 | 27.76 | 1733 | 6465 | 0.2680 | 0.6917 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.26 | 27.76 | 1757 | 6465 | 0.2717 | 0.6946 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.26 | 27.76 | 774 | 6465 | 0.1197 | 0.5269 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.26 | 27.76 | 2323 | 6465 | 0.3593 | 0.7559 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 64.97 | 27.76 | 1832 | 6656 | 0.2752 | 0.6988 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 64.97 | 27.76 | 1862 | 6656 | 0.2797 | 0.7023 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 64.97 | 27.76 | 808 | 6656 | 0.1214 | 0.5317 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 64.97 | 27.76 | 2297 | 6656 | 0.3451 | 0.7482 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 66.67 | 27.76 | 1842 | 6695 | 0.2751 | 0.6991 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 66.67 | 27.76 | 1870 | 6695 | 0.2793 | 0.7023 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 66.67 | 27.76 | 799 | 6695 | 0.1193 | 0.5289 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 66.67 | 27.76 | 2444 | 6695 | 0.3650 | 0.7609 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.37 | 27.76 | 1896 | 6879 | 0.2756 | 0.7008 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.37 | 27.76 | 1921 | 6879 | 0.2793 | 0.7036 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.37 | 27.76 | 912 | 6879 | 0.1326 | 0.5513 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.37 | 27.76 | 2522 | 6879 | 0.3666 | 0.7629 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.08 | 27.76 | 1899 | 6849 | 0.2772 | 0.7019 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.08 | 27.76 | 1923 | 6849 | 0.2807 | 0.7045 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.08 | 27.76 | 929 | 6849 | 0.1356 | 0.5554 | MN20160318_Q01 | M14 |